Ignite Creation Date:
2025-12-25 @ 12:12 AM
Ignite Modification Date:
2026-01-05 @ 2:13 PM
Study NCT ID:
NCT00541658
Status:
COMPLETED
Last Update Posted:
2013-04-22
First Post:
2007-10-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis
Sponsor:
Warner Chilcott
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-10
Start Date Type:
None
Primary Completion Date:
2010-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-04
Completion Date Type:
ACTUAL
First Submit Date:
2007-10-05
First Submit QC Date:
None
Study First Post Date:
2007-10-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-04-13
Results First Submit QC Date:
None
Results First Post Date:
2011-06-21
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-04-15
Last Update Post Date:
2013-04-22
Last Update Post Date Type:
ESTIMATED